Validation processes of protein biomarkers in serum-A cross platform comparison

Sensors (Switzerland)

Volumn 12, Issue 9, 2012, Pages 12710-12728

  Köhler, Katja ^a   Seitz, Harald ^a  

^a FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

Author keywords

Antibody antigen interaction; Clinical proteomics and diagnostic; Multi analyte immunoassays; Serum screening

Indexed keywords

ANTIBODY-ANTIGEN INTERACTIONS; CLINICAL PROTEOMICS; HYDROPHOBIC/HYDROPHILIC; IMMOBILIZATION EFFICIENCY; MULTI-ANALYTES; NONSPECIFIC ADSORPTION; TERTIARY STRUCTURES; VERIFICATION PROCESS;

ADSORPTION; ANTIBODIES; ANTIGENS; ASSAYS; BIOMARKERS; CELL IMMOBILIZATION; CHEMICAL PROPERTIES; IMMUNOLOGY; MICROARRAYS; MOLECULAR BIOLOGY; SURFACE PLASMON RESONANCE;

BODY FLUIDS;

ANTIBODY; BIOLOGICAL MARKER; LIGAND; PEPTIDE; PROTEIN;

ADSORPTION; ANIMAL; ANTIBODY-ANTIGEN INTERACTION; BLOOD; CHEMISTRY; CLINICAL PROTEOMICS AND DIAGNOSTIC; HUMAN; IMMUNOASSAY; METHODOLOGY; MULTI-ANALYTE IMMUNOASSAYS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SERUM SCREENING; SIGNAL NOISE RATIO; SURFACE PLASMON RESONANCE;

ANTIBODY-ANTIGEN INTERACTION; CLINICAL PROTEOMICS AND DIAGNOSTIC; MULTI-ANALYTE IMMUNOASSAYS; SERUM SCREENING;

ADSORPTION; ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; LIGANDS; PEPTIDES; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; SIGNAL-TO-NOISE RATIO; SURFACE PLASMON RESONANCE;

EID: 84867025309     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120912710     Document Type: Review

References (66)

1. Paulovich, A.G.; Whiteaker, J.R.; Hoofnagle, A.N.; Wang, P. The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2008, 2, 1386-1402.
2. Fontela, P.S.; Pai, N.P.; Schiller, I.; Dendukuri, N.; Ramsay, A.; Pai, M. Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: Evaluation using QUADAS and STARD standards. PLoS One 2009, 4, e7753.
3. Ransohoff, D.F. Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 2005, 5, 142-149.
4. Chen, R.; Snyder, M. Systems biology: Personalized medicine for the future. Curr. Opin. Pharmacol. 2012, 12, 1-6.
5. Anderson, N.L.; Anderson, N.G. The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell Proteomics 2002, 1, 845-867.
6. Wild, D. Standardization and Calibration. In The Immunoassay Handbook, 3rd ed.; Wild, D., Ed.; Elsevier Ltd.: Oxford, UK, 2005; Chapter 9, pp. 167-176.
7. Petricoin, E.F.; Ardekani, A.M.; Hitt, B.A.; Levine, P.J.; Fusaro, V.A.; Steinberg, S.M.; Mills, G.B.; Simone, C.; Fishman, D.A.; Kohn, E.C. et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
8. Li, Y.; Zeng, J.; Shi, J.; Wang, M.; Rao, M.; Xue, C.; Du, Y.; He, Z.-G. A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development. J. Proteome Res. 2010, 9, 4812-4822.
9. Littleton, E.; Dreger, M.; Palace, J.; Vincent, A. Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies. Mol. Cell Proteomics 2009, 8, 1688-1696.
10. Pitarch, A.; Abian, J.; Carrascal, M.; Sánchez, M.; Nombela, C.; Gil, C. Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004, 4, 3084-3106.
11. Liotta, L.A.; Petricoin, E.F. Mass Spectrometry-Based Protein Biomarker Discovery: Solving the Remaining Challenges to Reach the Promise of Clinical Benefit. Clin. Chem. 2010, 56, 1641-1642.
12. Zolg, J.W.; Langen, H. How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers. Mol. Cell Proteomics 2004, 3, 345-354.
13. Service, R.F. Proteomics ponders prime time. Science 2008, 321, 1758-1761.
14. Hueber, W.; Utz, P.J.; Robinson, W.H. Autoantibodies in early arthritis: Advances in diagnosis and prognostication. Clin. Exp. Rheumatol. 2003, 21, S59-S64.
15. Van Venrooij, W.J.; Vossenaar, E.R.; Zendman, A.J. Anti-CCP antibodies: The new rheumatoid factor in the serology of rheumatoid arthritis. Autoimmun. Rev. 2004, 3, S17-S19.
16. Von Mühlen, C.A.; Tan, E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 1995, 24, 323-358.
17. Mosier, D.E. HIV-1 envelope evolution and vaccine efficacy. Curr. Drug Targets Infect. Disord. 2005, 5, 171-177.
18. Miller, J.C.; Zhou, H.; Kwekel, J.; Cavallo, R.; Burke, J.; Butler, E.B.; Teh, B.S.; Haab, B.B. Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers. Proteomics 2003, 3, 56-63.
19. Whiteaker, J.R.; Zhao, L.; Zhang, H.Y.; Feng, L.-C.; Piening, B.D.; Anderson, L.; Paulovich, A. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem. 2007, 362, 44-54.
20. Leng, S.X.; McElhaney, J.E.; Walston, J.D.; Xie, D.; Fedarko, N.S.; Kuchel, G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63, 879-884.
21. Yalow, R.S.; Berson, S.A. Immunoassay of endogenous plasma in man. J. Clin. Invest. 1960, 39, 1157-1175.
22. Engvall, E.; Perlmann, P. Enzyme-linked immunosorbent assay (ELISA) Quantitative assay of immunoglobuline G. Immunochemistry 1971, 8, 871-874.
23. Ekins, R.P. Multi-analyte Immunoassay. J. Pharm. Biomed. Anal. 1989, 7, 155-168.
24. Ekins, R.P. Immunoassay and other ligand assays: From isotopes to luminescence. J. Clin. Ligand Assay 1999, 22, 61-77.
25. Schena, M.; Shalon, D.; Davis, R.W.; Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270, 467-470.
26. MacBeath, G.; Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination. Science 2000, 289, 1760-1763.
27. Haab, B.B.; Dunham, M.J.; Brown, P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001, 2, 1-13.
28. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; Kampf, C.; Wester, K.; Hober, S. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
29. Taussig, M.J.; Stoevesandt, O.; Borrebaeck, C.A.K.; Bradbury, A.R.; Cahill, D.; Cambillau, C.; de Daruvar, A.; Dübel, S.; Eichler, J.; Frank, R. et al. ProteomeBinders: Planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 2007, 4, 13-17.
30. Rimini, R.; Schwenk, J.M.; Sundberg, M.; Sjöberg, R.; Klevebring, D.; Gry, M.; Uhlén, M.; Nilsson, P. Validation of serum protein profiles by a dual antibody array approach. J. Proteomics 2009, 73, 252-266.
31. Kusnezow, W.; Syagailo, Y.V.; Rüffer, S.; Klenin, K.; Sebald, W.; Hoheisel, J.D.; Gauer, C.; Goychuk, I. Kinetics of antigen binding to antibody microspots: Strong limitation by mass transport to the surface. Proteomics 2006, 6, 794-803.
32. Miersch, S.; LaBaer, J. Nucleic Acid programmable protein arrays: Versatile tools for array-based functional protein studies. Curr. Protoc. Protein Sci. 2011, doi:10.1002/0471140864.ps2702s64.
33. Sibani, S.; LaBaer, J. Immunoprofiling using NAPPA protein microarrays. Methods Mol. Biol. 2011, 723, 149-161.
34. Zhu, H.; Snyder, M. Protein chip technology. Curr. Opin. Chem. Biol. 2003, 7, 55-63.
35. Wong, L.S.; Khan, F.; Micklefield, J. Selective Covalent Protein Immobilisation: Strategies and Application. Chem. Rev. 2009, 109, 4025-4053.
36. Guo, A.; Zhu, X.-Y. The Critical Role of Surface Chemistry in Protein Microarrays. In Functional Protein Microarrays in Drug Discovery, 1st ed.; Predki, P.F., Ed.; CRC Press: Boca Raton, FL, USA, 2007; Chapter 4, pp. 53-71.
37. Schulze, H.; Ross, A.J.; Ember, S.W.J.; Luby, J.; Khondoker, M.; Giraud, G.; Ciani, I.; Tlili, C.; Papale, D.; Terry, J.G. et al. Peptide-tags for enhanced DNA microarray performance. Faraday Discuss. 2011, 149, 201-210.
38. Andresen, H.; Grötzinger, C.; Zarse, K.; Birringer, M.; Hessenius, C.; Kreuzer, O.J.; Ehrentreich-Förster, E.; Bier, F.F. Peptide microarrays with site-specifically immobilized synthetic peptides for antibody diagnostics. Sens. Actuators B Chem. 2006, 113, 655-663.
39. Cretich, M.; Pirri, G.; Damin, F.; Solinas, I.; Chiari, M. A new polymeric coating for protein microarrays. Anal. Biochem. 2004, 332, 67-74.
40. Schröder, C.; Alhamdani, M.S.; Fellenberg, K.; Bauer, A.; Jacob, A.; Hoheisel, J.D. Robust protein profiling with complex antibody microarrays in a dual-colour mode. Methods Mol. Biol. 2011, 785, 203-221.
41. Hiller, R.; Laffer, S.; Harwanegg, C.; Huber, M.; Schmidt, W.M.; Twardosz, A.; Barletta, B.; Becker, W.M.; Blaser, K.; Breiteneder, H. et al. Microarrayed allergen molecules: Diagnostic gatekeepers for allergy treatment. FASEB J. 2002, 16, 414-416.
42. Robinson, W.H.; DiGennaro, C.; Hueber, W.; Haab, B.B.; Kamachi, M.; Dean, E.J.; Fournel, S.; Fong, D.; Genovese, M.C.; Neuman de Vegvar, H.E. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8, 295-301.
43. Andresen, H.; Bier, F.F. Peptide Microarrays for Serum Antibody Diagnostics. Methods Mol. Biol. 2009, 509, 123-134.
44. Frank, R. The SPOT-synthesis technique: Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 2002, 267, 13-26.
45. Andresen, H.; Grötzinger, C.; Zarse, K.; Kreuzer, O.J.; Ehrentreich-Förster, E.; Bier, F.F. Functional peptide Microarrays for specific and sensitive antibody diagnostics. Proteomics 2006, 6, 1376-1384.
46. Nahtman, T.; Jernberg, A.; Mahdavifar, S.; Zerweck, J.; Schutkowski, M.; Maeurer, M.; Reilly, M. Validation of peptide epitope microarray experiments and extraction of quality data. J. Immunol. Methods 2007, 328, 1-13.
47. Bongartz, J.; Bruni, M.; Or-Guil, M. Epitope Mapping using randomly generated peptide libraries. Methods Mol. Biol. 2009, 524, 237-246.
48. Wong, S.J.; Demarest, V.L.; Boyle, R.H.; Wang, T.; Ledizet, M.; Kar, K.; Kramer, L.D.; Fikrig, E.; Koski, R.A. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J. Clin. Microbiol. 2004, 42, 65-72.
49. Earle, C.D.; King, E.M.; Tsay, A.; Pittman, K.; Saric, B.; Vailes, L.; Godbout, R.; Oliver, K.G.; Chapman, M.D. High-throughput fluorescent multiplex array for indoor allergen exposure assessment. J. Allergy Clin. Immunol. 2007, 119, 428-433.
50. Mueller, G.A.; Gosavi, R.A.; Krahn, J.M.; Edwards, L.L.; Cuneo, M.J.; Glesner, J.; Pomés, A.; Chapman, M.D.; London, R.E.; Pedersen, L.C. The Der p 5 crystal structure provides insight into the Group 5 dust mite allergens. J. Biol. Chem. 2010, 285, 25394-25401.
51. Ovsyannikova, I.G.; Vailes, L.D.; Li, Y.; Heymann, P.; Chapman, M.D. Monoclonal antibodies to group II Dermatophagoides spp. allergens: Murine immune response, epitope analysis, and development of a two-site ELISA. J. Allergy Clin. Immunol. 1994, 94, 537-546.
52. Chruszcz, M.; Chapman, M.D.; Vailes, L.D.; Stura, E.A.; Saint-Remy, J.-M.; Minor, W.; Pomés, A. Crystal structures of mite allergens Der f 1 and Der p 1 reveal differences in surface-exposed residues that may influence antibody binding. J. Mol. Biol. 2009, 386, 520-530.
53. Li, M.; Gustchina, A.; Alexandratos, J.; Wlodawer, A.; Wünschmann, S.; Kepley, C.L.; Chapman, M.D.; Pomés, A. Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J. Biol. Chem. 2008, 283, 22806-22814.
54. Abreu, I.; Laroche, P.; Bastos, A.; Issert, V.; Cruz, M.; Nero, P.; Fonseca, J.E.; Branco, J.; Machado Caetano, J.A. Multiplexed immunoassay for detection of rheumatoid factors by FIDISTM technology. Ann. N.Y. Acad. Sci. 2005, 1050, 357-363.
55. Binnicker, M.J.; Jespersen, D.J.; Harring, J.A.; Rollins, L.O.; Beito, E.M. Evaluation of multiplex flow Immunoassay for detection of Epstein-Barr virus-specific antibodies. Clin. Vaccine Immunol. 2008, 15, 1410-1413.
56. Klutts, S.; Ford, B.A.; Perez, N.R.; Gronowski, A.M. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. J. Clin. Microbiol. 2009, 47, 3204-3210.
57. Klutts, J.S.; Liao, R.S.; Dunne, W.M., Jr.; Gronowski, A.M. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status. J. Clin. Microbiol. 2004, 42, 4996-5000.
58. Waterboer, T.; Sehr, S.; Pawlita, M. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 2006, 309, 200-204.
59. Kusnezow, W.; Syagailo, Y.V.; Rüffer, S.; Baudenstiel, N.; Gauer, C.; Hoheisel, J.D.; Wild, D.; Goychuk, I. Optimal design of microarray immunoassays to compensate for kinetic limitations: Theory and experiment. Mol. Cell Proteomics 2006, 5, 1681-1696.
60. Rich, R.L.; Myszka, D.G. Why you should be using more SPR biosensor technology. Drug Discov. Today Technol. 2004, 1, 301-308.
61. Nagel, T.; Gajovic-Eichelmann, N.; Tobisch, S.; Schulte-Spechtel, U.; Bier, F.F. Serodiagnosis of lyme borreliosis infection using surface plasmon resonance. Clin. Chim. Acta 2008, 394, 110-113.
62. De Boer, A.R.; Hokke, C.H.; Deelder, A.M.; Wuhrer, M. Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconj. J. 2008, 25, 75-84.
63. Vaisocherová, H.; Mrkvová, K.; Piliarik, M.; Jinoch, P.; Šteinbachová, M.; Homola, J. Surface plasmon resonance biosensor for direct detection of antibody against Epstein-Barr virus. Biosens. Bioelectron. 2007, 22, 1020-1026.
64. Battaglia, T.M.; Masson, J.-F.; Sierks, M.R.; Beaudoin, S.P.; Rogers, J.; Foster, K.N.; Holloway, G.A.; Booksh, K.S. Quantification of cytokines involved in wound healing using surface plasmon resonance. Anal. Chem. 2005, 77, 7016-7023.
65. Weinhart, M.; Grunwald, I.; Wyszogrodzka, M.; Gaetjen, L.; Hartwig, A.; Haag, R. Linear poly (methyl glycerol) and linear polyglycerol as potent protein and cell resistant alternatives to poly (ethylene glycol). Chem. Asian J. 2010, 5, 1992-2000.
66. Fasolo, J.; Snyder, M. Protein Microarrays. Methods Mol. Biol. 2009, 548, 209-222.